Furthermore, the transfer of HIF1A stabilizing long noncoding RNA (HISLA) from TAMs reportedly increases BC resistance to chemotherapeutics through HIF-1α stabilisation and subsequent inhibition of apoptosis [138]. Here, HIF1A is linked to breast cancer.